Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: initial (387), budding (11), early (483)

Post-enucleation socket syndrome (PESS) - patient information

Description: This factsheet contains information about post-enucleation socket syndrome (PESS).
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Post-enucleation-socket-syndrome-PESS-3169-PIL.pdf

InP IVE-Epirubicin-Etoposide-Ifosfamide Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE (IVE) Inpatient Regimen Regimen • Lymphoma – InP-IVE-Epirubicin-Etoposide-Ifosfamide Indication • Non Hodgkin’s Lymphoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-IVE-Epirubicin-Etoposide-Ifosfamide.pdf

Preventing infection - patient information

Description: Preventing infection Information for patients 3 At University Hospital Southampton NHS Foundation Trust (UHSFT) we take i
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Preventinginfection-patientinformation.pdf

ARC SETT project EOI v2 final

Description: Building analytic capability to address compound pressure across health and care systems: testing an approach. Expression of interest: Operational modelling and
Url: /Media/Southampton-Clinical-Research/Downloads/ARC-SETT-project-EOI-v2-final.pdf

Cyclophosphamide Docetaxel Epirubicin (100) Fluorouracil Pertuzumab Trastuzumab FE100CT-HP

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN (100)- FLUOROURACILPERTUZUMAB-TRASTUZUMAB (FE100CT-HP) Regimen • Breast Cancer – Cyclophosphamide-Docetaxel-Epirubicin (100)-FluorouracilPertuzumab-Trastuzumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Docetaxel-Epirubicin-100-Fluorouracil-Pertuzumab-Trastuzumab-FE100CT-HP.pdf

CT colonography (with hyoscine butylbromide) - patient information

Description: This factsheet contains information and advice following a CT colonography (with hyoscine butylbromide).
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/CT-colonography-with-hyoscine-butylbromide-2217-PIL.pdf

Diabetes: managing your foot wound - patient information

Description: You have been given this factsheet to help you recover from your foot ulcer or recent foot surgery. Please keep it
Url: /Media/UHS-website-2019/Patientinformation/Diabetes/Diabetes-managing-your-foot-wound-1473-PIL.pdf

Using water for labour and birth - patient information

Description: We have given you this factsheet because you may be considering using water during the labour and birth of your baby
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Using-water-for-labour-and-birth-1681-PIL.pdf

Hepatitis B in pregnancy - patient information

Description: Patient information factsheet Hepatitis B in pregnancy All pregnant women are offered a blood test for hepatitis B as part of
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Hepatology/Hepatitis-B-in-pregnancy-917-PIL.pdf

Talimogene laherparepvec (T-VEC)

Description: Chemotherapy Protocol SKIN CANCER Talimogene laherparepvec (T-VEC) Regimen • Skin – Talimogene laherparepvec (T-VEC) Indication • Talimogene laherparepvec (T-VEC) is recommended
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Talimogene-laherparepvec-T-VEC.pdf

341 to 350 of 1000

Previous … 33 34 35 36 37 … Next